This inventor holds 1 USPTO granted patent. Top assignee: Flow Pharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Charles V Herst: Inventor of Controlled-Release Antibody Technology.
Introduction
Charles V Herst is an inventor based in Oakland, California, and is associated with Flow Pharma, Inc. His work includes a patent concerning controlled release of antibodies to modulate cytokines.
Latest Patents
Herst is credited with 1 patent, titled “Controlled Release of Antibodies to Modulate Cytokines.” The patent describes an injectable formulation containing siltuximab encapsulated in poly(lactic-co-glycolic acid), or PLGA, microspheres. The microspheres are designed to release the antibody over hours, days, and weeks, with the release rate characterized by an absorption-rate constant.
The invention describes potential use in treating human patients with infections, including viral infections involving SARS-CoV, using siltuximab.
Career Highlights
Herst’s listed patent reflects work on antibody delivery through biocompatible polymer microspheres. The approach is intended to provide controlled release of a therapeutic antibody over an extended period.
Collaborations
Herst is associated with Flow Pharma, Inc. His listed coworkers include Scott Burkholtz and Tom Hodge.
Conclusion
Charles V Herst’s patent focuses on controlled-release delivery of siltuximab using PLGA microspheres, highlighting his contribution to antibody formulation and infection-treatment research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile